[1]
Sudipto Chatterjee et al. 2024. A comparative study of efficacy and tolerability of bepotastine besilate (1.5%) and olopatadine hydrochloride (0.1%) eye drops in allergic conjunctivitis in a tertiary care hospital of the southern part of India. Asian Journal of Medical Sciences. 15, 10 (Oct. 2024), 9–14.